| Item Type | Name |
|
Academic Article
|
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
|
|
Academic Article
|
Tolerogenic immunosuppression for organ transplantation.
|
|
Academic Article
|
Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts.
|
|
Academic Article
|
Combined liver-kidney transplants: allosensitization and recipient outcomes.
|
|
Academic Article
|
Small bowel transplantation: current progress and clinical application.
|
|
Academic Article
|
FK 506 versus cyclosporine in pediatric liver transplantation.
|
|
Academic Article
|
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
|
|
Academic Article
|
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface.
|
|
Academic Article
|
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
|
|
Academic Article
|
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
|
|
Academic Article
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
|
Academic Article
|
The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system.
|
|
Academic Article
|
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.
|
|
Academic Article
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
|
Academic Article
|
Clinical intestinal transplantation.
|
|
Academic Article
|
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
|
|
Academic Article
|
Weaning of immunosuppression in liver transplant recipients.
|
|
Academic Article
|
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
|
|
Academic Article
|
Clinical small bowel or small bowel plus liver transplantation under FK 506.
|
|
Academic Article
|
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
|
|
Academic Article
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
|
Academic Article
|
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
|
|
Academic Article
|
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.
|
|
Academic Article
|
Clinical intestinal transplantation in 1998: Pittsburgh experience.
|
|
Academic Article
|
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model.
|
|
Academic Article
|
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
|
|
Academic Article
|
Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation.
|
|
Academic Article
|
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
|
|
Academic Article
|
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy.
|
|
Academic Article
|
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.
|
|
Academic Article
|
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
|
|
Academic Article
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
|
Academic Article
|
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.
|
|
Academic Article
|
Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts.
|
|
Academic Article
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
|
Academic Article
|
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.
|
|
Academic Article
|
Explanation for loss of the HLA matching effect.
|
|
Academic Article
|
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.
|
|
Academic Article
|
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation.
|
|
Academic Article
|
Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts.
|
|
Academic Article
|
The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
|
|
Academic Article
|
Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
|
|
Academic Article
|
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts.
|
|
Academic Article
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
|
Academic Article
|
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
|
|
Academic Article
|
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
|
|
Academic Article
|
Immunosuppression in liver transplantation: beyond calcineurin inhibitors.
|
|
Academic Article
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
|
Academic Article
|
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
|
|
Academic Article
|
Perioperative donor bone marrow infusion in recipients of organ allografts.
|
|
Academic Article
|
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
|
|
Academic Article
|
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation.
|
|
Academic Article
|
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease.
|
|
Academic Article
|
Long-term survival of heart and liver xenografts with splenectomy and FK 506.
|
|
Academic Article
|
Tolerance and chimerism in liver transplantation.
|
|
Academic Article
|
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
|
|
Academic Article
|
Impact of Orthoclone OKT3 on liver transplantation.
|
|
Academic Article
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
|
Academic Article
|
Invasive aspergillosis in liver transplant recipients: outcome comparison of therapy with amphotericin B lipid complex and a historical cohort treated with conventional amphotericin B.
|
|
Academic Article
|
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival.
|
|
Academic Article
|
Mechanisms of protection from humoral rejection by a xenografted liver.
|
|
Academic Article
|
Future prospects in immunosuppression for liver transplantation.
|
|
Academic Article
|
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years.
|
|
Academic Article
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
|
Academic Article
|
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles.
|
|
Academic Article
|
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
|
|
Academic Article
|
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.
|
|
Academic Article
|
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
|
|
Academic Article
|
Current status of intestinal transplantation in children.
|
|
Academic Article
|
OKT3 in the reversal of acute hepatic allograft rejection.
|
|
Academic Article
|
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
|
|
Academic Article
|
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
|
|
Academic Article
|
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.
|
|
Academic Article
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
|
Academic Article
|
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
|
|
Academic Article
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
|
Academic Article
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
|
Academic Article
|
Adjuvant bone marrow infusion in clinical organ transplant recipients.
|
|
Academic Article
|
Immunosuppression: evolution in practice and trends, 1994-2004.
|
|
Academic Article
|
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1.
|
|
Academic Article
|
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.
|
|
Academic Article
|
FK 506 in solid organ transplantation.
|
|
Academic Article
|
Present state of immunosuppressive therapy in liver transplant recipients.
|
|
Academic Article
|
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
|
|
Academic Article
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
|
Academic Article
|
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
|
|
Academic Article
|
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
|
|
Academic Article
|
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
|
|
Academic Article
|
Weaning of immunosuppression in long-term liver transplant recipients.
|
|
Academic Article
|
The effect of splenectomy on cardiac and liver xenografts in the nude rat.
|
|
Academic Article
|
De novo malignancies after intestinal and multivisceral transplantation.
|
|
Academic Article
|
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients.
|
|
Academic Article
|
Long-term results of pancreas transplantation under tacrolius immunosuppression.
|
|
Academic Article
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
|
Academic Article
|
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
|
|
Academic Article
|
Effect of OKT3 on survival and rate of retransplantation.
|
|
Academic Article
|
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.
|
|
Academic Article
|
De novo malignancies after liver transplantation: a major cause of late death.
|
|
Academic Article
|
Role of splenectomy in human liver transplantation under modern-day immunosuppression.
|
|
Academic Article
|
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center.
|
|
Academic Article
|
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
|
|
Academic Article
|
Use of FK 506 in pediatric patients.
|
|
Academic Article
|
Near-total human face transplantation for a severely disfigured patient in the USA.
|
|
Academic Article
|
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls.
|
|
Academic Article
|
Infections with FK 506 immunosuppression: preliminary results with primary therapy.
|
|
Academic Article
|
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
|
|
Academic Article
|
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells.
|
|
Academic Article
|
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
|
|
Academic Article
|
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
|
|
Academic Article
|
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
|
|
Academic Article
|
Liver transplantation under cyclosporine: a decade of experience.
|
|
Academic Article
|
Overview of FK506 in transplantation.
|
|
Academic Article
|
The many faces of multivisceral transplantation.
|
|
Academic Article
|
Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration.
|
|
Academic Article
|
Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression.
|
|
Academic Article
|
Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression.
|
|
Academic Article
|
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.
|
|
Academic Article
|
Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression.
|
|
Grant
|
COMBINED BONE MARROW AND ORGAN TRANSPLANTATION IN HUMANS
|
|
Grant
|
ORTHOTOPIC LIVER TRANSPLANTATION
|